Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study

By Gu Yian   Shore Roy   Arslan Alan   Koenig Karen   Liu Mengling   Ibrahim Sherif   Lokshin Anna   Zeleniuch-Jacquotte Anne  

Cancer Causes and Control, Vol. 21, Iss. 8, 2010-08 ,pp. : 1323-1333

Springer Publishing Company

Access to resources Recommend Favorite

Motility and trafficking in B-cell non-Hodgkin's lymphoma (Review)

By      

International Journal of Oncology, Vol. 45, Iss. 1, 2014-01 ,pp. : 5-12

Spandidos Publications

Access to resources Recommend Favorite

CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab

By DiJoseph John   Dougher Maureen   Armellino Douglas   Kalyandrug Lyka   Kunz Arthur   Boghaert Erwin   Hamann Philip   Damle Nitin  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1107-1117

Springer Publishing Company

Access to resources Recommend Favorite

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy

By                          

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 109-114

Spandidos Publications

Access to resources Recommend Favorite

Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case–control study

By Mildon Katherine  

Cancer Causes and Control, Vol. 21, Iss. 12, 2010-12 ,pp. : 2079-2083

Springer Publishing Company

Access to resources Recommend Favorite